Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Bioadaptives (BDPT) Gross Profit (2019 - 2025)

Bioadaptives' Gross Profit history spans 7 years, with the latest figure at $3851.0 for Q3 2025.

  • For Q3 2025, Gross Profit fell 52.22% year-over-year to $3851.0; the TTM value through Sep 2025 reached $4914.0, down 66.77%, while the annual FY2024 figure was $4030.0, 62.75% down from the prior year.
  • Gross Profit for Q3 2025 was $3851.0 at Bioadaptives, up from $1063.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $8060.0 in Q3 2024 and bottomed at $429.0 in Q2 2024.
  • The 5-year median for Gross Profit is $2153.0 (2022), against an average of $2650.2.
  • The largest annual shift saw Gross Profit surged 2180.27% in 2021 before it crashed 71.21% in 2024.
  • A 5-year view of Gross Profit shows it stood at $1142.0 in 2021, then decreased by 9.81% to $1030.0 in 2022, then surged by 162.04% to $2699.0 in 2023, then skyrocketed by 198.63% to $8060.0 in 2024, then crashed by 52.22% to $3851.0 in 2025.
  • Per Business Quant, the three most recent readings for BDPT's Gross Profit are $3851.0 (Q3 2025), $1063.0 (Q2 2025), and $8060.0 (Q3 2024).